T12	Treatment 89 109	high-dose cytarabine
T13	Subject 113 137	patients who develop PPE
T14	Effect 171 189	potential toxicity
T15	Sub-Disorder 134 137	PPE
T16	Dosage 89 98	high-dose
T17	Drug 99 109	cytarabine
T18	Treat-Disorder 287 312	haematologic malignancies
